MissionIR Articles

Sernova Corp. (OTC: SEOVF) is a clinical stage regenerative medicine company focused on developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated…

Provectus Biopharmaceuticals, Inc. (NYSE: PVCT) specializes in developing oncology and dermatology therapies. PV-10, the company’s novel investigational drug for cancer, is designed for injection into solid tumors, thereby reducing potential for systemic side effects. Its…

Pressure BioSciences, Inc. (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant and…

Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Controlled-release means releasing a drug into the bloodstream or at a target site in the body,…

RedHill Biopharma Ltd. (NASDAQ: RDHL) is an Israeli biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage drugs for the treatment of inflammatory and gastrointestinal diseases, including cancer. The company is working…

OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) is headquartered in Baton Rouge, Louisiana, and is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to…

Viking Therapeutics, Inc. (NASDAQ: VKTX) is a clinical stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. The company has a portfolio that includes five therapeutic programs either in clinical…

Relmada Therapeutics, Inc. (OTC: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in…

DanDrit Biotech USA, Inc. (OTC: DDRT) was founded in 2001 and is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit was founded based on the research of…

Heat Biologics (NASDAQ: HTBX) is developing novel therapies that activate a patient’s immune system against cancer. The company’s T cell-stimulating platform technologies, ImPACT and ComPACT, form the basis of its product candidates. In combination with…

Cesca Therapeutics, Inc. (NASDAQ: KOOL) is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The company is focused on developing and manufacturing automated blood and bone marrow…

Guided Therapeutics, Inc. (OTC: GTHP) has developed a biophotonic technology for the early detection of disease that leads to cancer. The technology uses light to detect disease at the cellular level and provide immediate results…

Can-Fite BioPharma Ltd. (NYSE: CANF) is an Israeli biopharmaceutical company with pharmaceutical discovery and clinical development stage capabilities, developing treatments for cancer, inflammatory disease, and sexual dysfunction. The company’s CF101 drug candidate is currently under…